AGENUS INC Insider Acquires 10,000 Shares
Ticker: AGEN · Form: 4 · Filed: Apr 21, 2026 · CIK: 0001098972
| Field | Detail |
|---|---|
| Company | Agenus Inc (AGEN) |
| Form Type | 4 |
| Filed Date | Apr 21, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-transaction, stock-options, form-4
TL;DR
AGENUS INC insider Garo exercised options for 10k shares on 4/17. Bullish signal?
AI Summary
On April 17, 2026, Armen Garo, a reporting person for AGENUS INC, acquired 10,000 shares of common stock through the exercise of stock options. The transaction was reported on a Form 4 filing accepted by the SEC on April 21, 2026.
Why It Matters
This filing indicates an insider's belief in the company's value, as they are exercising options to gain more ownership. It provides insight into potential future performance.
Risk Assessment
Risk Level: low — This is a routine Form 4 filing reporting the exercise of stock options by an insider, which is common and not inherently risky.
Key Numbers
- 10,000 — Shares Acquired (Through exercise of stock options by insider Armen Garo.)
- 2026-04-17 — Transaction Date (Date of stock option exercise.)
- 2026-04-21 — Filing Date (Date the Form 4 was accepted by the SEC.)
Key Players & Entities
- AGENUS INC (company) — Issuer
- Armen Garo (person) — Reporting Person
- 10,000 shares (dollar_amount) — Shares acquired
FAQ
What was the exercise price of the stock options?
The filing does not specify the exercise price of the stock options.
What is Armen Garo's relationship to AGENUS INC?
Armen Garo is identified as a 'Reporting Person' for AGENUS INC.
How many shares does Armen Garo beneficially own after this transaction?
The filing does not provide information on Armen Garo's total beneficial ownership after the transaction.
What is the business of AGENUS INC?
AGENUS INC is in the business of Biological Products, (No Diagnostic Substances).
What is the CIK number for AGENUS INC?
The CIK number for AGENUS INC is 0001098972.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 21, 2026 by Armen Garo regarding AGENUS INC (AGEN). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.